• OPEN AN ACCOUNT
Indian Indices
Sensex
74,764.23 -813.35
( -1.08%)
Global Indices
Nasdaq
52,820.00 -615.25
(-1.15%)
Dow Jones
7,695.68 -43.92
(-0.57%)
Hang Seng
65,089.68 -179.65
(-0.28%)
Nikkei 225
10,811.26 -10.87
(-0.10%)
Forex
USD-INR
94.51 0.08
(0.08%)
EUR-INR
109.83 0.16
(0.15%)
GBP-INR
127.88 0.26
(0.20%)
JPY-INR
0.61 0.01
(0.93%)

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500660
INE159A01016
132.2958859
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAXO
46.87
49613.95
EPS(TTM)
Face Value()
Div & Yield %
62.48
10
1.95
 

vikas globalone ltd
UR Sugar Industries standalone net profit declines 50.00% in the March 2026 quarter
May 19,2026
Net profit of UR Sugar Industries declined 50.00% to Rs 0.11 crore in the quarter ended March 2026 as against Rs 0.22 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net profit rose 4.76% to Rs 0.44 crore in the year ended March 2026 as against Rs 0.42 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.